Emc Capital Management Innoviva, Inc. Transaction History

Emc Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$12.37 - $13.89 $304,264 - $341,652	24,597 Added 609.74%	28,631 $372,000
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $280,159 - $337,470	-24,597 Reduced 85.91%	4,034 $435,000
Q2 2022 Aug 12, 2022	BUY	$14.32 - $19.88 $1,045 - $1,451	73 Added 0.26%	28,631 $423,000
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $439,507 - $578,299	28,558 New	28,558 $487,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.